Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hutchmed China Ltd ADR (HCM)

Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hutchmed China Ltd ADR 48TH FLOOR CHEUNG KONG CENTER 2 QUEEN`S ROAD CENTRAL HONG KONG K3 00000 HKG

www.hutch-med.com Employees: 1,811 P: 852-2121-3888 F: +852 2121 8281

Sector:

Medical

Description:

HUTCHMED Limited is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. HUTCHMED Limited, formerly known as HUTCHMED (China) Limited, is based in HONG KONG.

Key Statistics

Overview:

Market Capitalization, $K 2,725,159
Enterprise Value, $K 2,653,999
Shares Outstanding, K 174,466
Float, K 168,185
% Float 96.40%
Short Interest, K 380
Short Float 0.22%
Days to Cover 11.65
Short Volume Ratio 0.57
% of Insider Shareholders 3.60%
% of Institutional Shareholders 8.82%

Financials:

Annual Sales, $ 630,200 K
Annual Net Income, $ 37,730 K
Last Quarter Sales, $ 75,806 K
Last Quarter Net Income, $ -61,254 K
EBIT, $ 0 K
EBITDA, $ -31,370 K

Growth:

1-Year Return 11.54%
3-Year Return -21.39%
5-Year Return -51.05%
5-Year Revenue Growth 207.58%
5-Year Earnings Growth 127.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/18/26
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Year -0.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

HCM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 31.68
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 5.99%
Debt/Equity 0.08
Price/Sales 4.55
Price/Cash Flow 55.88
Price/Book 2.25
Book Value/Share 7.12
Interest Coverage -0.61
60-Month Beta 0.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar